CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer

Project: Research project

Description

CD133-Targeted Natural Killer Cell Therapy for Aggressive Prostate Cancer
StatusActive
Effective start/end date8/1/197/31/22

Funding

  • U.S. DEPARTMENT OF DEFENSE

Fingerprint

Cell- and Tissue-Based Therapy
Natural Killer Cells
Prostatic Neoplasms